Johnson & Johnson (NY:JNJ)

MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025.

4 med tech stocks with improving prognosis for 2024

January 31, 2024

Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.

Abbott Laboratories on track for new highs in 2024

January 25, 2024

Intuitive Surgical had a solid quarter, but strength was expected, and the stock sold off; a healthy correction is good, but will investors buy the dip?

Intuitive Surgical’s post-earnings dip is a healthy time to buy

January 25, 2024

Johnson & Johnson's dividend is safe for 2024 and may include another increase for this Dividend King. Results suggest another solid quarter for medtech.

Topics Artificial Intelligence

Johnson & Johnson's stock price is at a critical turning point

January 23, 2024

Management remarks about how they plan to use technology to drive growth could matter just as much as near-term financials for these personal care companies.

Topics Intellectual Property

3 personal care stocks that smell like good earnings plays

January 23, 2024

Topics Artificial Intelligence

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

January 23, 2024

WK Kellogg, Newmont, and WEC Energy Group have upside potential as undervalued stocks, although each is navigating challenges that pushed valuations lower.

3 undervalued stocks: Is now the right time to buy?

January 22, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Merck, the Dow's hottest stock, gets set to report Q4 financials

January 08, 2024

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer

Topics Stocks

January 08, 2024

Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.

Are defensive sectors ready to outshine growth in 2024?

January 06, 2024

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024

January 02, 2024

Asana stock plunged as investors sold the news on its bullish earnings report, but with the company raising guidance, it may be time for investors buy the dip -

Asana sold the rip. Is it time to buy the dip?

December 12, 2023

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

December 11, 2023

Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 07, 2023

Increased automation will continue to support Credit Union's Growth and MissionNEW YORK - Dec. 6, 2023 - PRLog -- Leading global AI-powered credit decision platform provider, Scienaptic AI, announced...

Financial Resources Federal Credit Union Goes Live With Scienaptic's AI Platform

December 06, 2023

Via PRLog

Topics Artificial Intelligence

Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review

December 05, 2023

No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet.

Doing Your Holiday Shopping? These Stocks Might Make Great Gifts

December 04, 2023

Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors

Topics Bonds

November 30, 2023

Johnson & Johnson MedTech Acquires Laminar, Inc.

November 30, 2023

From Johnson & Johnson MedTech

J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown

J&J, Gilead, BMS: A look at undervalued dividend payers

November 29, 2023

146 U.S. companies went public in 2023, down 16.09% from last year. Despite market ups and downs, the Renaissance index of IPOs is outperforming the S&P 500

2023's most anticipated IPOs weren't always the big winners

November 29, 2023

Daily Wear Contact Lenses Market May See a Big Move: Major Giants Alcon, Hydron, Lagado Corporation, Metro Optics, Johnson & Johnson Vision Care ↗

Topics ETFs Initial Public Offering Stocks

November 28, 2023

According to HTF Market Intelligence, the Global Daily Wear Contact Lenses Market Breakdown by Application (Corrective Lenses, Therapeutic Lenses, Cosmetic Lenses, Lifestyle-Oriented Lenses) by Type...

Via SBWire

Teva Pharma is the way to play the re-rise of generic drugs

November 28, 2023

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

Heart Failure Drugs Market Critical Analysis with Expert Opinion : Johnson & Johnson, Pfizer, Roche ↗

November 24, 2023

Global Heart Failure Drugs Market Breakdown by Application (Reduced Ejection Fraction, Preserved Ejection Fraction) by Type (ACE inhibitors, Beta Blockers, Diuretics, Sacubitril Valsartan, Others) by...

Via SBWire

Skin Tightening Products Market to Witness Massive Growth by 2029 : L'Oréal, Johnson & Johnson, Amway ↗

November 22, 2023

Stay up to date with Skin Tightening Products Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Memory Implants Market Set for More Growth : NextMind, Johnson & Johnson, Neuralink

November 16, 2023

Get Memory Implants Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

Johnson & Johnson to Host Enterprise Business Review

November 16, 2023